Delivering Value To Those We Serve

News Releases

  • April 21, 1999 at 12:00 AM EDT
    FOSTER CITY, CA , April 21, 1999 - DepoMed, Inc. (AMEX: DMI) today announced that Bristol-Myers Squibb Company (NYSE: BMY) will not exercise a license and development option to use DepoMed's Gastric Retention (GR) System for an undisclosed pharmaceutical product.
  • March 1, 1999 at 12:00 AM EST
    FOSTER CITY, CA - March 1, 1999 - DepoMed, Inc. (AMEX: DMI) reported revenues of $763,000 for the year ended December 31, 1998, compared to $605,000 for the year ended December 31, 1997. The Company recorded a net loss of $2,780,000, or $0.44 per share, for the year ended December 31, 1998 compared
  • February 11, 1999 at 12:00 AM EST
    FOSTER CITY, Calif., - February 11, 1999 - Executives at DepoMed, Inc. (AMEX: DMI) will present at the Cruttenden Roth Eleventh Annual Growth Stock Conference today. DepoMed, Inc. is engaged in the development of controlled-release drug delivery technologies designed to improve the efficacy and
  • December 7, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., – December 7, 1998 ..... DepoMed, Inc. (AMEX: DMI) today announced the appointment of Bret Berner, Ph.D., as Vice President, Product Development. Dr. Berner was most recently Vice President, Development at Cygnus Therapeutic Systems.
  • November 6, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., - November 6, 1998 .. DepoMed, Inc. (Nasdaq: DPMD) announced that its common stock and warrants (Nasdaq: DPMDW) have been approved for listing on the American Stock Exchange under the symbols "DMI" and "DMIW," respectively. The Company expects trading to begin on Monday,
  • November 2, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., - November 2, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $217,687 for the quarter ended September 30, 1998 compared to $104,454 for the quarter ended September 30, 1997. The Company reported a net loss of $645,496, or $0.10 per share, for the quarter
  • August 5, 1998 at 12:00 AM EDT
    FOSTER CITY, CALIF., - August 5, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $130,000 for the quarter ended June 30, 1998 compared to $225,000 for the quarter ended June 30, 1997. The Company reported a loss of $586,000, or $0.09 per share, for the quarter ended June 30,
  • May 15, 1998 at 12:00 AM EDT
    FOSTER CITY, CALIF., - May 15, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $110,000 for the quarter ended March 31, 1998 compared to $127,000 for the quarter ended March 31, 1997. The Company reported a loss of $493,000, or $0.08 per share, for the quarter ended March 31,
  • March 19, 1998 at 12:00 AM EST
    FOSTER CITY, CA - March 19, 1998 - DepoMed, Inc. (Nasdaq: DPMD) reported revenues of $605,000 for the year ended December 31, 1997, resulting from research and development payments in connection with its ongoing development work with Bristol-Myers Squibb. Revenues were $318,000 in 1996.
  • March 4, 1998 at 12:00 AM EST
    FOSTER CITY, CA - March 4, 1998 - DepoMed, Inc. (Nasdaq: DPMD) announced that it has entered into a research collaboration with the R. W. Johnson Pharmaceutical Research Institute (PRI), a Johnson & Johnson unit, to study the feasibility of an orally administered, controlled release pharmaceutical